Same Indication

Ipilimumab vs Omeprazole

Ipilimumab vs Omeprazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Omeprazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Omeprazole: Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Omeprazole — 0.5-1 hour.

Chemical Properties

Molecular Formula: Omeprazole — C17H19N3O3S.

Molecular Weight: Omeprazole — 345.4170 g/mol.

Type: Ipilimumab — Antibody; Omeprazole — Small molecule.